Data spanning the past 90 days through February 10, 2026 reveals that AN2 Therapeutics's three principal insider shareholders consist of TenPercentOwner Braden Michael Leonard (3.02Mn shares), TenPercentOwner Global Health Technology Fund, L.P. Adjuvant (2.37Mn shares), Chief Executive Officer Eric Easom (1.32Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Braden Michael Leonard | 3,017,432 | 16 Jun, 2025 | |
| Global Health Technology Fund, L.P. Adjuvant | 2,373,500 | 18 Jan, 2024 | |
| Eric Easom | Chief Executive Officer | 1,322,146 | 03 Jun, 2025 |
| Robin Shane Readnour | 661,650 | 23 Dec, 2024 | |
| Joseph S Zakrzewski | 551,418 | 11 Apr, 2025 | |
| Kabeer Aziz | 430,021 | 14 Jan, 2026 | |
| Capital Management, L.P. Ra | 300,853 | 13 Aug, 2024 | |
| Joshua M Eizen | Nan | 152,499 | 07 Jan, 2026 |
| Sanjay Chanda | Chief Development Officer | 75,823 | 07 Jan, 2026 |
| Lucy Day | Chief Financial Officer | 75,363 | 07 Jan, 2026 |
| Gilbert Lynn Marks | 75,309 | 14 Jan, 2026 | |
| Stephen David Prior | Chief Strategy Officer | 59,086 | 07 Jan, 2026 |
| Paul Eckburg | Chief Medical Officer | 51,416 | 29 Mar, 2024 |
| Kevin Michael Krause | Chief Strategy Officer | 31,914 | 29 Mar, 2024 |
| Patricia A. Martin | 16,905 | 14 Jan, 2026 | |
| Margaret M Fitzpatrick | 8,610 | 29 May, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 12 Jan, 2026 | Kabeer Aziz | Common Stock | A | 11,560 | $0.00 | 52,479 | D | A |
| 12 Jan, 2026 | Patricia A. Martin | Common Stock | A | 3,650 | $0.00 | 16,905 | D | A |
| 12 Jan, 2026 | Gilbert Lynn Marks | Common Stock | A | 11,560 | $0.00 | 75,309 | D | A |
| 06 Jan, 2026 | Sanjay Chanda | Common Stock | D | 5,956 | $1.01 | 75,823 | D | S |
| 06 Jan, 2026 | Lucy Day | Common Stock | D | 5,512 | $1.01 | 75,363 | D | S |
| 06 Jan, 2026 | Joshua M Eizen | Common Stock | D | 6,931 | $1.01 | 152,499 | D | S |
| 06 Jan, 2026 | Stephen David Prior | Common Stock | D | 2,858 | $1.01 | 59,086 | D | S |
| 05 Jan, 2026 | Sanjay Chanda | Common Stock | D | 3,295 | $1.00 | 81,779 | D | S |
| 05 Jan, 2026 | Lucy Day | Common Stock | D | 3,295 | $1.00 | 80,875 | D | S |
| 05 Jan, 2026 | Joshua M Eizen | Common Stock | D | 17,923 | $1.00 | 159,430 | D | S |
| 05 Jan, 2026 | Stephen David Prior | Common Stock | D | 3,604 | $1.00 | 61,944 | D | S |
| 04 Nov, 2025 | Joshua M Eizen | Common Stock | D | 2,819 | $1.14 | 177,353 | D | S |
| 04 Nov, 2025 | Stephen David Prior | Common Stock | D | 765 | $1.14 | 65,548 | D | S |
| 10 Oct, 2025 | Kabeer Aziz | Common Stock | A | 10,367 | $0.00 | 40,919 | D | A |
| 10 Oct, 2025 | Patricia A. Martin | Common Stock | A | 3,274 | $0.00 | 13,255 | D | A |
| 10 Oct, 2025 | Gilbert Lynn Marks | Common Stock | A | 10,367 | $0.00 | 63,749 | D | A |
| 10 Jul, 2025 | Kabeer Aziz | Common Stock | A | 11,875 | $0.00 | 30,552 | D | A |
| 10 Jul, 2025 | Patricia A. Martin | Common Stock | A | 3,750 | $0.00 | 9,981 | D | A |
| 10 Jul, 2025 | Gilbert Lynn Marks | Common Stock | A | 11,875 | $0.00 | 53,382 | D | A |
| 02 Jun, 2025 | Eric Easom | Common Stock | A | 10,000 | $1.07 | 256,380 | D | P |